Next Article in Journal
Development and Validation of Liquid Chromatography-Based Methods to Assess the Lipophilicity of Cytotoxic Platinum(IV) Complexes
Next Article in Special Issue
Molecular Theranostic Agents for Photodynamic Therapy (PDT) and Magnetic Resonance Imaging (MRI)
Previous Article in Journal
Fluorolytic Sol–Gel Synthesis of Nanometal Fluorides: Accessing New Materials for Optical Applications
Previous Article in Special Issue
A Semi-Empirical Method for the Estimation of the Hydration Number of Mn(II)-Complexes
Article Menu
Issue 4 (December) cover image

Export Article

Open AccessReview
Inorganics 2018, 6(4), 129;

Targeted Contrast Agents for Molecular MRI

Centre de Biophysique Moléculaire, Rue Charles Sadron, 45071 Orléans CEDEX 2, France
Received: 8 November 2018 / Revised: 27 November 2018 / Accepted: 30 November 2018 / Published: 4 December 2018
(This article belongs to the Special Issue MRI Contrast Agents)
PDF [3393 KB, uploaded 6 December 2018]


Molecular magnetic resonance imaging (MRI) provides information non-invasively at cellular and molecular levels, for both early diagnosis and monitoring therapeutic follow-up. This imaging technique requires the development of a new class of contrast agents, which signal changes (typically becomes enhanced) when in presence of the cellular or molecular process to be evaluated. Even if molecular MRI has had a prominent role in the advances in medicine over the past two decades, the large majority of the developed probes to date are still in preclinical level, or eventually in phase I or II clinical trials. The development of novel imaging probes is an emergent active research domain. This review focuses on gadolinium-based specific-targeted contrast agents, providing rational design considerations and examples of the strategies recently reported in the literature. View Full-Text
Keywords: MRI; molecular imaging; targeted contrast agent; lanthanide; protein-based contrast agent MRI; molecular imaging; targeted contrast agent; lanthanide; protein-based contrast agent

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Lacerda, S. Targeted Contrast Agents for Molecular MRI. Inorganics 2018, 6, 129.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Inorganics EISSN 2304-6740 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top